NATURAL PRODUCT RESEARCH AND DEVELOPMENT ›› 2017, Vol. 29 ›› Issue (7): 1102-1106. doi: 10.16333/j.1001-6880.2017.7.004
• Article • Previous Articles Next Articles
LI Di-di,CHEN Yang,TAN Wan-xian,ZOU Wen-jun*
Online:
Published:
Abstract: Pseudoprotodioscinis the main active compound of Di’aoXinXue Kang capsules.To explore the effect of pseudoprotodioscin on cyclooxygenase-2 (COX-2) expression induced by OX-LDL in human umbilical vein endothelial cells (HUVEC),HUVEC cells were cultured in vitro. After pretreatment with different concentrations of pseudoprotodioscin for 24 h,OX-LDL was added for the induction of COX-2 expression.The expressions of COX-2 mRNA was detected by Real-time PCR,and the expression of COX-2 protein and the phosphorylation of mitogen activated protein kinase (MAPK) associated with COX-2 inflammatory signaling pathway were determined by Western blot.Our results showed that pseudoprotodioscin can inhibit OX-LDL-induced COX-2 expression in HUVEC dose-dependently,and inhibit TLR2 expression and p38MAPK activity.These results indicated that pseudoprodioscininhibited OX-LDL-induced COX-2 expression possibly via affecting the TLR2 / p38MAPK pathway,suggesting its anti-inflammatory effect on vein endothelial cells.
Key words: Pseudoprotodioscin, OX-LDL, human umbilical vein endothelial cells, cyclooxygenase-2, TLR2/P38MAPK pathway
LI Di-di,CHEN Yang,TAN Wan-xian,ZOU Wen-jun*. Effect of Pseudoprotodioscin on OX-LDL-induced COX-2 Expression in HUVEC[J]. NATURAL PRODUCT RESEARCH AND DEVELOPMENT, 2017, 29(7): 1102-1106.
0 / / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.trcw.ac.cn/EN/10.16333/j.1001-6880.2017.7.004
https://www.trcw.ac.cn/EN/Y2017/V29/I7/1102